BCL2L1 and invasive carcinoma: Consistent with this, β-cell-specific knockout of Bcl-XL in the same model was shown to decrease the incidence of invasive carcinoma and increase that of encapsulated, non-invasive tumors [27], supporting the hypothesis that Bcl-XL promotes the invasion and metastasis of pancreatic tumors in vivo.